<?xml version="1.0" encoding="UTF-8"?>
<p>Previous investigations around the world have shown that the prevalence of HIVDR varies in different regions, during different time periods and in different target populations. WHO reported that the prevalence of any HIVDR among all individuals receiving treatment ranged from 3% to 29% [
 <xref rid="B10" ref-type="bibr">10</xref>]. In the past few years, the proportion of HIVDR in China has remained relatively low, at 5.4% in 2011 and 1.1% in 2015 among treatment-experienced patients [
 <xref rid="B11" ref-type="bibr">11</xref>]. However, these reports are sporadic and limited, and continuous monitoring is still needed.
</p>
